SCHEMBL25940658

SCHEMBL25940658

Cc1c(Br)c2cccnc2n1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FEN1 P39748 1/20 0.46
TNKS O95271 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
NPC1 O15118 1/20 0.39
HSP90AA1 P07900 1/20 0.39
SLC6A2 P23975 1/20 0.37
HTT P42858 1/20 0.37
EGFR P00533 1/20 0.37
SRC P12931 1/20 0.37
ELANE P08246 1/20 0.37
HPGD P15428 2/20 0.36
KDM4E B2RXH2 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
HTR6 P50406 1/20 0.36
ALDH1A1 P00352 1/20 0.36
DYRK1A Q13627 1/20 0.35
KMT2A Q03164 1/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6663570 0.81 FEN1 (0.49) FEN1TNKSL3MBTL1NPC1HSP90AA1
SCHEMBL23089259 0.78 PTGDR2 (0.42) FEN1EGFRSRCELANEHPGD
SCHEMBL1609990 0.78 FEN1 (0.56) FEN1TNKSL3MBTL1NPC1HSP90AA1
SCHEMBL30731036 0.75 FEN1 (0.48) FEN1TNKSL3MBTL1HSP90AA1EGFR
SCHEMBL8976235 0.73 FEN1 (0.42) FEN1TNKSHTTEGFRSRC
SCHEMBL18991307 0.72 POLB (0.40) FEN1ELANEPTGDR2
SCHEMBL31405314 0.72 POLB (0.40) FEN1ELANEPTGDR2
SCHEMBL12395945 0.71 FEN1 (0.41) FEN1TNKSEGFRSRCELANE
SCHEMBL8137623 0.71 HTR6 (0.43) FEN1TNKSL3MBTL1HTR6PTGDR2
SCHEMBL15635129 0.71 PTGDR2 (0.64) CYP2C19HTR6PTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230391752-A1 PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AND RELATED USES CHULALONGKORN UNIVERSITY (TH) 2023-12-07 US disclosed
EP-4209492-A1 COMPOUND FOR TREATING THROMBOTIC DISEASES Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2023-07-12 EP disclosed
WO-2022087422-A9 PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AND RELATED USES CHULALONGKORN UNIVERSITY (TH) 2022-06-09 WO disclosed
WO-2022087422-A1 PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AND RELATED USES CHULALONGKORN UNIVERSITY (TH) 2022-04-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230391752-A1 PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AND RELATED USES GLS2, PYGL, CPS1 FEN1 3473/4885TNKS 3155/4885L3MBTL1 4303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.